Search

Maria O Bachynsky

from Newtown, PA
Age ~80

Maria Bachynsky Phones & Addresses

  • 178 Andrew Dr, Newtown, PA 18940 (201) 303-3905
  • 38 Carrie Ct, Nutley, NJ 07110 (973) 667-6943
  • Newark, NJ
  • 178 Andrew Dr, Newtown, PA 18940 (908) 715-1856

Work

Position: Food Preparation and Serving Related Occupations

Education

Degree: High school graduate or higher

Publications

Us Patents

Capecitabine Rapidly Disintegrating Tablets

View page
US Patent:
20080085310, Apr 10, 2008
Filed:
Sep 25, 2007
Appl. No.:
11/860708
Inventors:
Maria Oksana Bachynsky - Nutley NJ, US
Martin Howard Infeld - Upper Montclair NJ, US
Mohammad Rashed - Randolph NJ, US
Navnit Hargovindas Shah - Clifton NJ, US
International Classification:
A61K 31/7064
A61K 9/30
US Classification:
424465, 514 49
Abstract:
There is provided a film coated pharmaceutical composition comprising 5′-deoxy-5-fluoro-N-[(pentyloxy)-carbonyl]-cytidine (capecitabine) and at least one disintegrant selected from the group comprising of crospovidone (particle size

Novel Pharmaceutical Dosage Forms Comprising Valganciclovir Hydrochloride

View page
US Patent:
20080146591, Jun 19, 2008
Filed:
Dec 11, 2007
Appl. No.:
12/001290
Inventors:
Maria Oksana Bachynsky - Nutley NJ, US
Martin Howard Infeld - Upper Montclair NJ, US
Navnit Hargovindas Shah - Clifton NJ, US
International Classification:
A61K 31/546
A61P 31/22
US Classification:
51426337
Abstract:
The present invention provides novel solid pharmaceutical dosage forms for oral administration, after being constituted in water. The solid dosage forms comprise a therapeutically effective amount of valganciclovir hydrochloride and a non-hygroscopic organic acid present in an amount sufficient to stabilize the valganciclovir hydrochloride in a predetermined amount of water. The present invention also provides novel liquid pharmaceutical dosage forms for oral administration after constituting the solid pharmaceutical dosage form with water. A non-hygroscopic bulking agent may optionally be included in the above dosage form. These novel pharmaceutical dosage forms are useful in the treatment or control of viruses such as herpes simplex virus and cytomegalovirus. The present invention also provides a method for treating these diseases employing the solid and liquid pharmaceutical dosage forms and a method for preparing these pharmaceutical dosage forms.

Capecitabine Rapidly Disintegrating Tablets

View page
US Patent:
20110027374, Feb 3, 2011
Filed:
Nov 17, 2009
Appl. No.:
12/619918
Inventors:
Maria Oksana Bachynsky - Nutley NJ, US
Mohammad Rashed - Randolph NJ, US
Paul Anthony Samtak - Clifton NJ, US
Navnit Hargovindas Shah - Clifton NJ, US
International Classification:
A61K 31/506
A61K 9/14
A61P 35/00
US Classification:
424490, 514274
Abstract:
There is provided a film coated pharmaceutical composition comprising 5′-deoxy-5-fluoro-N-[(pentyloxy)-carbonyl]-cytidine (capecitabine) and at least one disintegrant selected from the group comprising of crospovidone (particle size

Absorption Enhancement Of Antibiotics

View page
US Patent:
51907488, Mar 2, 1993
Filed:
Dec 18, 1991
Appl. No.:
7/809244
Inventors:
Maria O. Bachynsky - Nutley NJ
Martin H. Infeld - Upper Montclair NJ
Navnit Shah - Clifton NJ
Joel Unowsky - Livingston NJ
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A61K 3174
US Classification:
424 7808
Abstract:
The absorption of antibiotics given through oral and rectal routes of administration is significantly enhanced by use of the antibiotic in conjunction with a two-component absorption enhancing system made up of an ether of a C. sub. 6 to C. sub. 18 alcohol and a polyoxyethylene glycol together with a second component selected from among polyoxyethylene glycol C. sub. 6 to C. sub. 18 glyceride esters, C. sub. 6 to C. sub. 18 carboxylic acids or salts thereof, and esters of two or more C. sub. 6 to C. sub. 18 carboxylic acids, glycerol and a polyoxyethylene glycol. A carrier and adjuvants are usually included. These compositions can be administered in any convenient oral or rectal dosage form, including tablets, capsules, beadlets and suppositories.

Method Of Treating Autoimmune Diseases Comprising Administration Of Psoralen Dosage Forms

View page
US Patent:
50361023, Jul 30, 1991
Filed:
Sep 14, 1990
Appl. No.:
7/582467
Inventors:
Maria O. Bachynsky - Nutley NJ
Martin H. Infeld - Upper Montclair NJ
Richard J. Margolis - Wayne NJ
Dennis A. Perla - Wayne NJ
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A61K 3135
US Classification:
514455
Abstract:
A method of treating leukocyte mediated autoimmune and skin diseases using psoralen reagent composition comprising sterile aqueous solutions suitable for extracorporeal administration to blood from a subject being treated by ultraviolet-A photophoresis.

Psoralen Reagent Compositions For Extracorporeal Treatment Of Blood

View page
US Patent:
49993755, Mar 12, 1991
Filed:
Apr 11, 1989
Appl. No.:
7/336179
Inventors:
Maria O. Bachynsky - Nutley NJ
Martin H. Infeld - Upper Montclair NJ
Richard J. Margolis - Wayne NJ
Dennis A. Perla - Wayne NJ
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A61K 3135
US Classification:
514455
Abstract:
Psoralen compositions for extracorporeal administration to blood prior to reinfusion into a subject comprising a sterile aqueous solution of about 0. 005 to about 1 mg/ml of a psoralen ethyl alcohol, propylene glycol and water and having a pH from about 2. 0 to about 6. 0 are disclosed. These compositions are useful for the therapy of a subject being treated by ultraviolet-A photophoresis.
Maria O Bachynsky from Newtown, PA, age ~80 Get Report